Literature DB >> 31037924

A Novel Mutation in NLRP7 Related to Recurrent Hydatidiform Mole and Reproductive Failure.

Jafar Fallahi1, Vahid Razban1, Mozhdeh Momtahan2, Mojgan Akbarzadeh-Jahromi3, Bahia Namavar-Jahromi2,4, Zahra Anvar2,5, Majid Fardaei1,6.   

Abstract

BACKGROUND: Hydatidiform mole (HM) is an abnormal human pregnancy with excessive trophoblastic proliferation and abnormal embryonic development, dividing into two complete HM (CHM) and partial HM (PHM) groups. One subcategory of the CHMs is recurrent and familial, which is known as biparental HM (BiHMs) or recurrent HM (RHM). NLRP7, KHDC3L and PADI6 are maternal-effect genes involved in RHMs. NLRP7 is a major gene responsible for RHMs. This study was performed on patients with molar pregnancies and miscarriage. The aim of this study was to genetic screen for mutations in NLRP7 and KHDC3L genes in an affected woman with previous history of 5RHM and the sibling with history of miscarriage.
MATERIALS AND METHODS: In this experimental study, DNA was extracted from blood samples. KHDC3L and NLRP7 were polymerase chain reaction (PCR) amplified. The PCR products were purified and Sanger sequenced.
RESULTS: In this study, there is no mutation in KHDC3L gene but a novel mutation was identified in the NACHT domain of NLRP7 gene. Patient with five recurrent moles had this mutation in the homozygous state while her sister with one miscarriage and one normal child showed this mutation in the heterozygous state.
CONCLUSION: In this study, we identified a new mutation in NLRP7 gene of a patient with recurrent HM. Following egg donation, this patient has a normal boy. The sister of this patient with heterozygous mutation has a spontaneous abortion and one normal child that confirm the impact of a defective allele of NLRP7 on reproductive wastage in a recent finding. Copyright© by Royan Institute. All rights reserved.

Entities:  

Keywords:  Hydatidiform Mole; KHDC3L; NLRP7

Year:  2019        PMID: 31037924      PMCID: PMC6500085          DOI: 10.22074/ijfs.2019.5657

Source DB:  PubMed          Journal:  Int J Fertil Steril        ISSN: 2008-0778


Introduction

Hydatidiform mole (HM) is an abnormal human conception with a defect in fetal development and growth (1). HM is divided into two categories, complete HM (CHM) and partial HM (PHM). CHMs are commonly androgenetic diploid conceptions (2) and PHMs are mostly dispermic triploid conceptions (3). Both CHM and PHM have an extra set of the paternal genome, therefore, paternal genes are more expressed and consequently show excessive trophoblastic proliferation (4). In most of the cases, HM is sporadic, however, in a subgroup of CHM, it is recurrent and familial condition which is known as biparental HM (BiHMs) or recurrent HM (RHM) (OMIM 231090). Occurrence of at least two moles in the same woman is referred to recurrent type and this form is inherited in an autosomal recessive fashion. Frequency of RHMs in the Middle and Far East is reported about 2.5% up to 9.4% of all HMs, which is twice or more compared to Western countries (5-9). So far, three maternal-effect genes, NLRP7, KHDC3L and recently PADI6, have been identified to be responsible for RHMs (10-12). It is suggested that these three genes function in setting genomic imprinting process (13). NLRP7 mutations have been reported in 48-80% of RHMs cases (14-19), while mutations in KHDC3L was only reported in 10-14% of these patients with no NLRP7 mutations (10, 20, 21). Homozygote or compound heterozygote mutations of these three genes have been observed in most of the affected women (22). There is still a few fractions of RHM patients with the unidentified responsible gene. NLRP7 is the principal gene responsible for RHMs, identified by Murdoch and colleagues in 2006. NLRP7 as the candidate of maternal-effect gene is responsible for RHMs and reproductive disorders such as spontaneous abortions and stillbirths (11). NLRP7, which encodes a protein with 1037 amino acids, is a member of the CATERPILLER protein family with four conserved and functional pyrine, 9-10 leucine-rich repeats, NACHT-associated domain (NAD) and a NACHT domain (Fig .1A) (23, 24). About 48% of intronic sequences of NLRP7 gene contain Alu repetitive elements. It is believed that Alu repeats act as a hot spot for INDEL mutations (20). To date, 60 pathogenic point and INDEL mutations have been reported in NLRP7 (20, 25). In this study, a new mutation was identified in NLRP7 gene in a patient with recurrent HM. This patient has a normal boy using egg donation. Also, the sister of this patient with heterozygous mutation has a spontaneous abortion and one normal child.
Fig 1

Deletion of the highly conserved Threonine amino acid from NACHT domain. A. NLRP7 protein domains including PYRIN, NACHT, NAD, leucine-rich repeats and ATP binding motif in the NACHT domain is depicted, B. Sequence chromatogram show deletion of CAC nucleotides in homozygote state in the patient’s NLRP7 gene, C. Heterozygote deletion of CAC nucleotides in her sister, D. Normal allele in the wild type individual, and E. Threonine 185 residue is highly conserved during evolution.

Materials and Methods

In this experimental study, two sisters with molar pregnancies and miscarriage referred to the Infertility Center in Shiraz University of Medical Sciences, Shiraz, Iran. In the patient, as proband, five moles were reported without any normal child. Patient’s sister represented one normal child and one miscarriage. Proband was diagnosed as BiHMs because she has more than two moles and genetic studies were performed on NLRP7 and KHDC3L genes. Genomic DNA was isolated from whole blood cells using DNA Kit (Cinnaclon, Iran). Three exons and intron boundaries of KHDC3L and 11 exons and intron boundaries of NLRP7 were polymerase chain reaction (PCR) amplified using our previously designed primers and conditions (20, 26). PCR products were purified and Sanger sequenced (Eurofins, Germany). The Ethics Committee of Shiraz University of Medical Sciences approved the study protocol and patients gave written consent to participate in the study (code: IR.SUMS.REC.1396.540).

Results

The sequence of NLRP7 and KHDC3L were analysed by Chromas software (Technelysium Pty Ltd, Australia). BLAST of sequences was performed for two genes based on the reference sequences in the NCBI database (NLRP7, NG_008056.1, and KHDC3L, NG_031942.1). Sequencing analysis of NLRP7 in the patient revealed a new three nucleotides deletion in exon 4 in a homozygous state (Fig .1B). Sequence analysis of the patient’s sister with one spontaneous abortion and one normal child showed a heterozygous deletion status for these three nucleotides (Fig .1C). Normal sequence is provided in Figure 1D. This deletion is expected to remove amino acid Threonine in codon 185 (c.555_557delCAC, p.Thr185del) . The mutation was evaluated by parameters of Mutation Taster (www.mutationtaster.org) and it was regarded as disease-causing alteration. In addition, the mutation was analysed by PROVEAN parameter (http://provean.jcvi.org). Variants with a score equal to or below -2.5 are considered "deleterious," and variants with a score above -2.5 are considered "neutral." PROVEAN score was estimated -13.000 for this mutation. This means that the mutation is deleterious. In addition, Threonine in codon 185 is conserved in various species using multiple sequence alignment by Clustal Omegam (www.ebi.ac.uk/Tools/msa/clustalo/) (Fig .1E). Histopathology of the molar tissue for the patient is provided in Figure 2. Excessive proliferation of trophoblastic tissue has been observed around chorionic villi, while fetal tissues were clearly absent. Deletion of the highly conserved Threonine amino acid from NACHT domain. A. NLRP7 protein domains including PYRIN, NACHT, NAD, leucine-rich repeats and ATP binding motif in the NACHT domain is depicted, B. Sequence chromatogram show deletion of CAC nucleotides in homozygote state in the patient’s NLRP7 gene, C. Heterozygote deletion of CAC nucleotides in her sister, D. Normal allele in the wild type individual, and E. Threonine 185 residue is highly conserved during evolution. Photomicrograph of molar tissue from the patient. Excessive proliferation of trophoblastic tissue is seen around chorionic villi (CV) by hematoxilin/eosin staining histopathology analysis (magnification: left: × 100, right × 40).

Discussion

In this study, a new mutation in the homozygous state has been identified within the NACHT domain of NLRP7 protein, suggesting the importance of this domain in normal function. This study on a patient with a homozygous mutation in NLRP7, while she has a healthy boy via ovum donation, add further evidence that pathology of RHM is restricted to the oocyte and normal ovum is able to rescue defects of these patients for normal pregnancies. To date, four cases of ovum donation in patients with a mild missense mutations in NLRP7 have been reported (27, 28). Investigations on healthy reproductive male individual with a homozygous mutation in NLRP7 show that function of this gene is not necessary for normal sperm, in contrast to ovum (14, 15). The sister of indicated patient with heterozygous mutation has a spontaneous abortion and one normal child, confirming the impact of the defective allele of NLRP7 on reproductive wastage, reported in recent finding (25).

Conclusion

We report a new mutation in NLRP7 gene, related to RHM and spontaneous abortion in homozygous and heterozygous states, respectively. Regarding this study and four previous reports, patients with homozygous mutation in NLRP7 are able to have live birth with egg donation. In contrast to four previously reported cases with a mild missense mutations, investigation on this new patient shows that more deleterious mutations with severe functional effect are also good candidate for egg donation.
  28 in total

1.  Parental origin and phenotype of triploidy in spontaneous abortions: predominance of diandry and association with the partial hydatidiform mole.

Authors:  M V Zaragoza; U Surti; R W Redline; E Millie; A Chakravarti; T J Hassold
Journal:  Am J Hum Genet       Date:  2000-05-05       Impact factor: 11.025

2.  The chance of malignancy in a repeated hydatidiform mole.

Authors:  H ACOSTA-SISON
Journal:  Am J Obstet Gynecol       Date:  1959-10       Impact factor: 8.661

3.  A recurrent intragenic genomic duplication, other novel mutations in NLRP7 and imprinting defects in recurrent biparental hydatidiform moles.

Authors:  Y C Kou; L Shao; H H Peng; R Rosetta; D del Gaudio; A F Wagner; T K Al-Hussaini; I B Van den Veyver
Journal:  Mol Hum Reprod       Date:  2007-11-26       Impact factor: 4.025

4.  A strong founder effect for two NLRP7 mutations in the Indian population: an intriguing observation.

Authors:  R Slim; R Bagga; W Chebaro; R Srinivasan; N Agarwal
Journal:  Clin Genet       Date:  2009-07-24       Impact factor: 4.438

5.  The demographics of molar pregnancies in England and Wales from 2000-2009.

Authors:  Philip Savage; Jennet Williams; Swee-Ling Wong; Dee Short; Sabrina Casalboni; Karina Catalano; Michael Seckl
Journal:  J Reprod Med       Date:  2010 Jul-Aug       Impact factor: 0.142

Review 6.  Genomic imprinting in gestational trophoblastic disease--a review.

Authors:  R A Fisher; M D Hodges
Journal:  Placenta       Date:  2003-04       Impact factor: 3.481

7.  Mutations in NALP7 cause recurrent hydatidiform moles and reproductive wastage in humans.

Authors:  Sharlene Murdoch; Ugljesa Djuric; Batool Mazhar; Muheiddine Seoud; Rabia Khan; Rork Kuick; Rashmi Bagga; Renate Kircheisen; Asangla Ao; Bhawna Ratti; Samir Hanash; Guy A Rouleau; Rima Slim
Journal:  Nat Genet       Date:  2006-02-05       Impact factor: 38.330

8.  Identification of 13 novel NLRP7 mutations in 20 families with recurrent hydatidiform mole; missense mutations cluster in the leucine-rich region.

Authors:  C M Wang; P H Dixon; S Decordova; M D Hodges; N J Sebire; S Ozalp; M Fallahian; A Sensi; F Ashrafi; V Repiska; J Zhao; Y Xiang; P M Savage; M J Seckl; R A Fisher
Journal:  J Med Genet       Date:  2009-02-25       Impact factor: 6.318

9.  Genetic and epigenetic analysis of recurrent hydatidiform mole.

Authors:  Bruce E Hayward; Michel De Vos; Nargese Talati; M Reza Abdollahi; Graham R Taylor; Esther Meyer; Denise Williams; Eamonn R Maher; Faridon Setna; Kausar Nazir; Shahnaz Hussaini; Hussain Jafri; Yasmin Rashid; Eamonn Sheridan; David T Bonthron
Journal:  Hum Mutat       Date:  2009-05       Impact factor: 4.878

10.  Expression analysis of the NLRP gene family suggests a role in human preimplantation development.

Authors:  Pu Zhang; Morag Dixon; Marco Zucchelli; Fredwell Hambiliki; Lev Levkov; Outi Hovatta; Juha Kere
Journal:  PLoS One       Date:  2008-07-23       Impact factor: 3.240

View more
  5 in total

1.  Pregnancy after oocyte donation in a patient with NLRP7 gene mutations and recurrent molar hydatidiform pregnancies.

Authors:  Claire Cozette; Florence Scheffler; Melyne Lombart; Jerome Massardier; Pierre-Adrien Bolze; Touria Hajri; Francois Golfier; Isabelle Touitou; Cecile Rittore; Jean Gondry; Philippe Merviel; Moncef Benkhalifa; Rosalie Cabry
Journal:  J Assist Reprod Genet       Date:  2020-06-26       Impact factor: 3.412

2.  The genetics of recurrent hydatidiform moles in Mexico: further evidence of a strong founder effect for one mutation in NLRP7 and its widespread.

Authors:  Mónica Aguinaga; Maryam Rezaei; Irma Monroy; Nawel Mechtouf; Javier Pérez; Elsa Moreno; Yolotzin Valdespino; Carolina Galaz; Guadalupe Razo; Daniela Medina; Raúl Piña; Rima Slim
Journal:  J Assist Reprod Genet       Date:  2021-03-22       Impact factor: 3.357

3.  Hydatidiform mole in the era of COVID-19 pandemic. Is there an association?

Authors:  Ahmed M Abbas; Omar A Ahmed; Asmaa S Shaltout
Journal:  Am J Reprod Immunol       Date:  2020-05-05       Impact factor: 3.886

4.  A possible association between hydatidiform mole and the COVID-19 pandemic: A retrospective cohort study.

Authors:  Ala Aiob; Karina Naskovica; Avishalom Sharon; Jacob Bornstein
Journal:  Gynecol Oncol       Date:  2021-03-05       Impact factor: 5.482

5.  High-Risk Gestational Trophoblastic Neoplasia from a Homozygous NLRP7 Mutation.

Authors:  Zachary A Kopelman; Erica R Hope
Journal:  Gynecol Oncol Rep       Date:  2021-06-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.